Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

No.	薬物名（臨床試験情報から抽出）	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	指定難病告示番号
1	**comment**- imp inhalation solution identical to ventavis inhalation solution, but imp is in a different volume presentation. please see covering letter.	-	-	-	-	1件: 86 💬
2	1 mg qd to 15 mg qd pf-06649751	Tavapadon	1件: D11431 💬	2件: DRD1, DRD5 💬	10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway	1件:  6  💬
3	1 mg qd to 7 mg qd pf-06649751 (if de-escalated in parent study)	Tavapadon	1件: D11431 💬	2件: DRD1, DRD5 💬	10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway	1件:  6  💬
4	10% metronidazole ointment	Metronidazole	3件: D00409, D05016, D05017 💬	-	-	1件: 96 💬
5	15 mg qd de-escalated to 7 mg qd pf-06649751 in parent study remain at 7 mg qd	Tavapadon	1件: D11431 💬	2件: DRD1, DRD5 💬	10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway	1件:  6  💬
6	15n2-tofacitinib	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 97 💬
7	3 mg qd to 15 mg qd pf-06649751	Tavapadon	1件: D11431 💬	2件: DRD1, DRD5 💬	10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway	1件:  6  💬
8	3 mg qd to 7 mg qd pf-06649751 (de-escalated in parent study)	Tavapadon	1件: D11431 💬	2件: DRD1, DRD5 💬	10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway	1件:  6  💬
9	3h-cholesterol bound to albumin	Cholesterol	1件: D00040 💬	-	-	2件: 259, 261 💬
10	7 mg qd to 15 mg qd pf-06649751	Tavapadon	1件: D11431 💬	2件: DRD1, DRD5 💬	10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway	1件:  6  💬
11	7 mg qd to 7 mg qd pf-06649751 (de-escalated in parent study)	Tavapadon	1件: D11431 💬	2件: DRD1, DRD5 💬	10件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway	1件:  6  💬
12	[f-18] fluorodopa positron emission tomography	-	-	-	-	1件:  6  💬
13	[tol	-	-	-	-	1件: 67 💬
14	[tolvaptan 15]	Tolvaptan	1件: D01213 💬	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	1件: 67 💬
15	[tolvaptan 30]	Tolvaptan	1件: D01213 💬	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	1件: 67 💬
16	[tolvaptan 45/15]	Tolvaptan	1件: D01213 💬	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	1件: 67 💬
17	Abatacept, rituximab or tocilizumab	Abatacept	3件: D02596, D02994, D03203 💬	4件: CD80, CD86, IL6R, MS4A1 💬	24件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor	1件: 46 💬
18	Abp 710 - biosimilar to infliximab	Infliximab	1件: D02598 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
19	Abp 798 - biosimilar to rituximab	Rituximab	1件: D02994 💬	1件: MS4A1 💬	1件: Hematopoietic cell lineage	1件: 46 💬
20	Abp 798 biosimilar to rituximab	Rituximab	1件: D02994 💬	1件: MS4A1 💬	1件: Hematopoietic cell lineage	1件: 46 💬
21	Abp 959 - biosimilar to eculizumab	Eculizumab	1件: D03940 💬	1件: C5 💬	9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus	1件: 62 💬
22	Abp 959 - proposed biosimilar to eculizumab	Eculizumab	1件: D03940 💬	1件: C5 💬	9件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus	1件: 62 💬
23	Ac-203 1% topical ointment	-	-	-	-	1件: 162 💬
24	Active topical ns2 1% dermatologic cream	-	-	-	-	1件: 160 💬
25	Adalimuab, etanercept, tocilizumab, or abatacept	Abatacept	3件: D00742, D02596, D03203 💬	5件: CD80, CD86, IL6R, LTA, TNF 💬	77件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
26	Adalimumab (up to 9 months exposure)	Adalimumab	1件: D02597 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
27	Adx-102 1% topical dermal cream (reproxalap)	-	-	-	-	1件: 160 💬
28	Alpha-tocopherol	Tocopherol	2件: D02331, D02332 💬	-	-	2件: 49, 206 💬
29	Alpha-tocotrienol quinone	Tocotrienol	-	-	-	1件: 156 💬
30	Alvelestat tosylate	Alvelestat	-	-	-	1件: 231 💬
31	Amoxicillin, metronidazole and tetracycline	Amoxicillin	7件: D00201, D00229, D00409, D02925, D05016, D05017, D07452 💬	-	-	1件: 97 💬
32	Androgel 1 % topical gel	-	-	-	-	1件: 13 💬
33	Anesthetic topical adhesive synera	-	-	-	-	1件: 13 💬
34	Antiepileptic drug (1 to 3 only)	-	-	-	-	1件: 158 💬
35	Apitox - pure honeybee toxin	-	-	-	-	1件: 13 💬
36	Ascorbic acid (vitamin c) and alpha-tocopherol (vitamin e)	Ascorbic acid	3件: D00018, D02331, D02332 💬	-	-	1件: 206 💬
37	Atomoxetine	Atomoxetine	2件: D02574, D07473 💬	1件: SLC6A2 💬	1件: Synaptic vesicle cycle	3件:  6 ,  8 , 13 💬
38	Autologous vitd3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides (toldc-vitd3)	-	-	-	-	1件: 13 💬
39	Avonex and topamax	-	-	-	-	1件: 13 💬
40	Azithromycin + metronidazole	Azithromycin	6件: D00409, D02134, D05016, D05017, D06390, D07486 💬	-	-	1件: 96 💬
41	Bdmard withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept)	Abatacept	5件: D00742, D02597, D02598, D03203, D04358 💬	4件: CD80, CD86, LTA, TNF 💬	71件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
42	Behavioral: physical activity together for pwms and their cgs (pat-ms)	-	-	-	-	1件: 13 💬
43	Bezafibrate (400mg) in addition to standard 15-20 mg/kg/jour udca therapy	Bezafibrate	2件: D00734, D01366 💬	2件: NR1H4, PPARA 💬	9件: Adipocytokine signaling pathway, Bile secretion, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway	1件: 94 💬
44	Biological: benralizumab, biological: placebo to mepolizumab	Benralizumab	2件: D04923, D09874 💬	2件: IL5, IL5RA 💬	13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation	1件: 44 💬
45	Biological: mepolizumab, biological: placebo to benralizumab	Benralizumab	2件: D04923, D09874 💬	2件: IL5, IL5RA 💬	13件: Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation	1件: 44 💬
46	Biosimilar product to adalimumab	Adalimumab	1件: D02597 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
47	Bony toxicity	-	-	-	-	1件: 34 💬
48	Botulinic toxin	-	-	-	-	1件: 36 💬
49	Botulinum a toxin	-	-	-	-	1件: 118 💬
50	Botulinum toxin	-	-	-	-	3件:  6 , 13, 149 💬
51	Botulinum toxin a	Botulinum toxin type A	1件: D00783 💬	1件: SNAP25 💬	2件: Insulin secretion, Synaptic vesicle cycle	4件: 13, 51, 149, 226 💬
52	Botulinum toxin a - haemagglutinin complex	Botulinum toxin type A	1件: D00783 💬	1件: SNAP25 💬	2件: Insulin secretion, Synaptic vesicle cycle	1件: 13 💬
53	Botulinum toxin type a	Botulinum toxin type A	1件: D00783 💬	1件: SNAP25 💬	2件: Insulin secretion, Synaptic vesicle cycle	10件:  2 ,  5 ,  6 ,  7 , 13, 15, 17, 70, 113, 149 💬
54	Botulinum toxin type a (nabota®) injection into the gastrocnemius muscle	Botulinum toxin type A	1件: D00783 💬	1件: SNAP25 💬	2件: Insulin secretion, Synaptic vesicle cycle	1件: 70 💬
55	Botulinum toxin type a 200u	Botulinum toxin type A	1件: D00783 💬	1件: SNAP25 💬	2件: Insulin secretion, Synaptic vesicle cycle	1件: 13 💬
56	Botulinum toxin type a 300u	Botulinum toxin type A	1件: D00783 💬	1件: SNAP25 💬	2件: Insulin secretion, Synaptic vesicle cycle	1件: 13 💬
57	Botulinum toxin type a infiltrations	Botulinum toxin type A	1件: D00783 💬	1件: SNAP25 💬	2件: Insulin secretion, Synaptic vesicle cycle	1件: 13 💬
58	Botulinum toxin type b	Botulinum Toxin Type B	1件: D02735 💬	1件: SNAP25 💬	2件: Insulin secretion, Synaptic vesicle cycle	3件:  2 ,  6 , 51 💬
59	Botulinum toxin type b (2500 units / vial)	Botulinum Toxin Type B	1件: D02735 💬	1件: SNAP25 💬	2件: Insulin secretion, Synaptic vesicle cycle	1件: 51 💬
60	Botulinum toxin type b (myobloc)	Botulinum Toxin Type B	1件: D02735 💬	1件: SNAP25 💬	2件: Insulin secretion, Synaptic vesicle cycle	2件:  2 ,  6  💬
61	Botulinum toxin(botox)	-	-	-	-	1件: 51 💬
62	Botulinum toxin: xeomin	-	-	-	-	1件:  6  💬
63	Botulism toxin treatment	-	-	-	-	1件: 161 💬
64	C-82 topical gel, 1%	-	-	-	-	1件: 51 💬
65	C-type natriuretic peptide conjugated to multi-arm polyethylene glycol carrier through a cleavable linker	Polyethylene glycol	1件: D03370 💬	-	-	1件: 276 💬
66	Ceftazidime and tobramycin	Ceftazidime	4件: D00063, D00921, D02542, D07654 💬	-	-	1件: 299 💬
67	Chong kun dang tofacitinib tablet	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 46 💬
68	Cistanche total glycosides	-	-	-	-	1件:  2  💬
69	Clindamycin	Clindamycin	4件: D00277, D01073, D01990, D02132 💬	-	-	2件: 46, 299 💬
70	Clobetasol 0.05% topical ointment	Clobetasol	1件: D07715 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 162 💬
71	Clostridium botulinum toxin type a	Botulinum toxin type A	1件: D00783 💬	1件: SNAP25 💬	2件: Insulin secretion, Synaptic vesicle cycle	1件: 13 💬
72	Cohort 1: hatg, csa, epag day 14 to month 6	Antilymphocyte immunoglobulin (horse)	1件: D08808 💬	-	-	1件: 60 💬
73	Cohort 2: hatg, csa, epag day 14 to month 3	Antilymphocyte immunoglobulin (horse)	1件: D08808 💬	-	-	1件: 60 💬
74	Cohort 2: nilotinib oral capsules (dose to be determined from cohort 1)	Nilotinib	1件: D08953 💬	4件: ABL1, KIT, PDGFRA, PDGFRB 💬	32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis	1件:  6  💬
75	Cohort 3: hatg, csa (dose reduced), epag day 1 to month 6	Antilymphocyte immunoglobulin (horse)	1件: D08808 💬	-	-	1件: 60 💬
76	Combination product: beclomethasone dipropionate in addition to mc-evoo	Beclomethasone dipropionate	2件: D00689, D07495 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
77	Combination product: beclomethasone dipropionate in addition to refined oil	Beclomethasone dipropionate	2件: D00689, D07495 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
78	Comparator: diclofenac	Diclofenac	3件: D00903, D00904, D07816 💬	2件: PTGS1, PTGS2 💬	23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway	1件: 46 💬
79	Comparator: diclofenac sodium	Diclofenac	3件: D00903, D00904, D07816 💬	2件: PTGS1, PTGS2 💬	23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway	1件: 46 💬
80	Corticoids+ tocilizumab 8mg/kg/4 weeks	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 41 💬
81	Cp-690,550 (tofacitinib)	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 46 💬
82	Cystic fibrosis ready to use supplemental food	-	-	-	-	1件: 299 💬
83	D-a-tocopheryl peg 1000 succinate	-	-	-	-	1件: 299 💬
84	Decrease tocilizumab, abatacept	Abatacept	2件: D02596, D03203 💬	3件: CD80, CD86, IL6R 💬	24件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor	1件: 46 💬
85	Denosumab - - immunoglobulin g2 human monoclonal antibody to rank ligand	Denosumab	1件: D03684 💬	1件: TNFSF11 💬	7件: Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis	1件: 274 💬
86	Denosumab - immunoglobulin g2 human monoclonal antibody to rank ligand	Denosumab	1件: D03684 💬	1件: TNFSF11 💬	7件: Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis	1件: 274 💬
87	Device: fourier domain doppler optical coherence tomography (fdoct)	-	-	-	-	1件: 13 💬
88	Device: frequently sampled oral glucose tolerance test and cgm	Dextrose, unspecified form	-	-	-	1件: 299 💬
89	Device: high-resolution peripheral quantitative computed tomography (hr-pqct)	-	-	-	-	1件: 46 💬
90	Device: home oral glucose tolerance test kit	Dextrose, unspecified form	-	-	-	1件: 299 💬
91	Device: integra titan™ total shoulder generation 1.0	Titanium	-	-	-	1件: 46 💬
92	Device: intermittent exposure to oxygen via oro-nasal mask	Oxygen	1件: D00003 💬	-	-	1件: 226 💬
93	Device: manual toothbrush	-	-	-	-	1件: 51 💬
94	Device: manual toothbrush and water flosser (philips sonicare airfloss)	Water	1件: D00001 💬	-	-	1件: 51 💬
95	Device: novel allergen-specific immune signature directed approach to dietary elimination therapy	-	-	-	-	1件: 98 💬
96	Device: optical coherence tomography (oct)	-	-	-	-	1件: 13 💬
97	Device: optical coherence tomography angiography (octa)	-	-	-	-	1件: 13 💬
98	Device: oxymizer® compared to cnc	-	-	-	-	1件: 85 💬
99	Device: primus fgti (flexible great toe implant)	Florasulam	-	-	-	1件: 46 💬
100	Device: sonic toothbrush	-	-	-	-	1件: 51 💬
101	Device: sonic toothbrush (philips sonicare) and water flosser (philips sonicare airfloss)	Water	1件: D00001 💬	-	-	1件: 51 💬
102	Device: tc-a ps total knee replacement system	-	-	-	-	1件: 46 💬
103	Device: tc-plus solution ps total knee replacement system	-	-	-	-	1件: 46 💬
104	Device: tobi podhaler	-	-	-	-	1件: 299 💬
105	Device: total hip arthoplasty (tha)	-	-	-	-	1件: 46 💬
106	Device: total hip arthroplasty (fitmore or cls uncemented femoral stem made by zimmer-biomet, warshaw, usa)	-	-	-	-	1件: 71 💬
107	Device: use of bioanalytical assay to monitor plasma levels of perhexiline	Methamidophos	2件: D05442, D08340 💬	8件: CACNA1C, CACNA1D, CACNA1F, CACNA1S, CPT1A, CPT1B, CPT1C, CPT2 💬	45件: AMPK signaling pathway, Adipocytokine signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, Fatty acid degradation, Fatty acid metabolism, GABAergic synapse, Glucagon signaling pathway, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin resistance, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, PPAR signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Thermogenesis, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 58 💬
108	Diagnostic test: 30 seconds sit to stand test	-	-	-	-	1件: 113 💬
109	Diagnostic test: 68ga-dota-toc pet/ct	-	-	-	-	1件: 84 💬
110	Diagnostic test: antibodies to golimumab	Golimumab	1件: D04358 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 97 💬
111	Diagnostic test: beam test to predict falls	Tricyclazole	-	-	-	1件:  6  💬
112	Diagnostic test: candy glucose tolerance test	Dextrose, unspecified form	-	-	-	1件: 299 💬
113	Diagnostic test: mixed meal tolerance test	-	-	-	-	1件: 298 💬
114	Diagnostic test: ocular coherence tomography-angiography (oct-a)	-	-	-	-	2件: 90, 301 💬
115	Diagnostic test: oral glucose tolerance test	Dextrose, unspecified form	-	-	-	3件: 13, 65, 299 💬
116	Diagnostic test: retrospective evaluation of endoscopy prior to study drug	-	-	-	-	1件: 98 💬
117	Diagnostic test: serum metal ion levels determined to monitor changes in chromium and cobalt levels	Chromium	-	-	-	1件: 46 💬
118	Diclofenac	Diclofenac	3件: D00903, D00904, D07816 💬	2件: PTGS1, PTGS2 💬	23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway	4件: 13, 34, 46, 271 💬
119	Diclofenac + omeprazole	Diclofenac	7件: D00455, D00903, D00904, D01207, D05259, D05261, D07816 💬	4件: ATP4A, ATP4B, PTGS1, PTGS2 💬	26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway	1件: 46 💬
120	Diclofenac 50 milligrams	Diclofenac	3件: D00903, D00904, D07816 💬	2件: PTGS1, PTGS2 💬	23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway	1件: 271 💬
121	Diclofenac sodium	Diclofenac	3件: D00903, D00904, D07816 💬	2件: PTGS1, PTGS2 💬	23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway	2件: 34, 46 💬
122	Diclofenac sodium topical gel	Diclofenac	3件: D00903, D00904, D07816 💬	2件: PTGS1, PTGS2 💬	23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway	1件: 13 💬
123	Diclofenac sr	Diclofenac	3件: D00903, D00904, D07816 💬	2件: PTGS1, PTGS2 💬	23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway	1件: 271 💬
124	Diphtheria toxoid	Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)	-	-	-	2件: 13, 46 💬
125	Dp mannitol	Mannitol	1件: D00062 💬	-	-	1件: 299 💬
126	Drug: tocilizmab	-	-	-	-	1件: 46 💬
127	Dry powder tobramycin	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
128	Edoxaban	Edoxaban	2件: D09546, D09710 💬	1件: F10 💬	1件: Complement and coagulation cascades	2件: 46, 88 💬
129	Egcg + tocotrienol	Epigallocatechin gallate	-	-	-	1件: 299 💬
130	Essential amino acid intake + leucine vs total aa supplement	Leucine	1件: D00030 💬	-	-	1件: 299 💬
131	Etanercepet, rituximab, abatacept, tocilizumab, sarilumab	Abatacept	4件: D02596, D02994, D03203, D10161 💬	4件: CD80, CD86, IL6R, MS4A1 💬	24件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor	1件: 46 💬
132	Evaluation of biological predictive factors of clinical response to ustekinumab	Ustekinumab	1件: D09214 💬	3件: IL12A, IL12B, IL23A 💬	26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus	1件: 96 💬
133	Exposure to golimumab	Golimumab	1件: D04358 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 97 💬
134	Exposure to one or more disease-modifying drug(s)(dmds) used to treat ms	-	-	-	-	1件: 13 💬
135	Fluocinolone acetonide	Fluocinolone	1件: D01825 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 90 💬
136	Gamma-tocopherol	Tocopherol	1件: D02332 💬	-	-	1件: 13 💬
137	Hov-12020 (palm tocotrienols complex)	-	-	-	-	1件: 124 💬
138	Human monoclonal antibody (cnto 1275) to interleukin 12p-40	-	-	-	-	1件: 96 💬
139	Human monoclonal antibody (cnto 1275) to interleukin-12p40	-	-	-	-	1件: 13 💬
140	Human serum albumin (hsa) fused to recombinant human growth hormone (hgh)	Albumin human	3件: D02691, D02792, D05424 💬	1件: GHR 💬	5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway	1件: 78 💬
141	Human serum albumin (hsa) fused to somatropin	Albumin human	3件: D02691, D02792, D05424 💬	1件: GHR 💬	5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway	1件: 78 💬
142	Idpm: inhaled dry powder mannitol	Mannitol	1件: D00062 💬	-	-	1件: 299 💬
143	Iduronate-2-sulfatase fused to a fc polypeptide that binds to the human transferrin receptor	-	-	-	-	1件: 19 💬
144	Iloprost therapy up to 2 ng/kg x min	Iloprost	1件: D02721 💬	1件: PTGIR 💬	3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	1件: 51 💬
145	In double-blind phase: treatment with tofacitinib	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 107 💬
146	In open-label phase: treatment with tofacitinib	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 107 💬
147	Incobotulinum toxin a	-	-	-	-	3件:  2 ,  6 , 13 💬
148	Inhaled dry powder mannitol	Mannitol	1件: D00062 💬	-	-	1件: 299 💬
149	Inhaled mannitol	Mannitol	1件: D00062 💬	-	-	1件: 299 💬
150	Inhaled tobramycin	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
151	Inn-tocilizumab	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 266 💬
152	Insulin glargine	Insulin glargine	1件: D03250 💬	1件: INSR 💬	22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway	1件: 299 💬
153	Interferon beta treatment to add-on atorvastatin treatment	Atorvastatin	3件: D00258, D00887, D07474 💬	1件: HMGCR 💬	4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis	1件: 13 💬
154	Intra-articular tocilizumab	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 46 💬
155	Intradetrusor injection of botulinum toxin-a	-	-	-	-	1件: 13 💬
156	Intravenous (i.v.) methylprednisolone 1000 mg, total 9	Methylprednisolone	6件: D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 222 💬
157	Intravesical injection of botulinum a toxin	-	-	-	-	2件:  6 , 17 💬
158	Ipd® (suplatast tosilate)	-	-	-	-	1件: 226 💬
159	Itraconazole	Itraconazole	1件: D00350 💬	-	-	4件:  3 , 65, 227, 299 💬
160	Itraconazole/voriconazole	Itraconazole	2件: D00350, D00578 💬	-	-	1件: 299 💬
161	Iv tobramycin	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
162	Jinarc - tolvaptan tablets	Tolvaptan	1件: D01213 💬	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	1件: 67 💬
163	Ketorolac	Ketorolac	2件: D00813, D08104 💬	2件: PTGS1, PTGS2 💬	23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway	2件: 70, 226 💬
164	Ketorolac tromethamine	Ketorolac	3件: D00396, D00813, D08104 💬	2件: PTGS1, PTGS2 💬	23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway	1件: 226 💬
165	Lapatinib	Lapatinib	2件: D04024, D08108 💬	2件: EGFR, ERBB2 💬	48件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Platinum drug resistance, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction	3件: 34, 74, 75 💬
166	Lentivirus-mediated delivery of arsa to the cns.	-	-	-	-	1件: 19 💬
167	Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field	-	-	-	-	1件: 13 💬
168	Lmx 4 topical cream	-	-	-	-	1件: 256 💬
169	Mannitol	Mannitol	1件: D00062 💬	-	-	4件:  6 , 60, 96, 299 💬
170	Mannitol + pulmozyme	Mannitol	1件: D00062 💬	-	-	1件: 299 💬
171	Mannitol inhalation powder	Mannitol	1件: D00062 💬	-	-	1件: 299 💬
172	Medication to suppress the immune system	-	-	-	-	1件: 19 💬
173	Metronidazole	Metronidazole	3件: D00409, D05016, D05017 💬	-	-	8件: 46, 51, 63, 94, 95, 96, 97, 291 💬
174	Metronidazole capsule 50 mg	Metronidazole	3件: D00409, D05016, D05017 💬	-	-	1件: 97 💬
175	Mobilization of stem cells to prepare for leukapheresis	-	-	-	-	1件: 96 💬
176	Modified oral glucose tolerance test (50g 4-hours)	Dextrose, unspecified form	-	-	-	1件: 299 💬
177	Mra (tocilizumab)	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	2件: 46, 107 💬
178	Mra(tocilizumab)	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	2件: 46, 107 💬
179	Msc2430913a or ono-4641 (to be used as synonyms)	-	-	-	-	1件: 13 💬
180	Msc_ntf cells transplantation by multiple intramuscular injections at 24 separate sites, in addition to a single intrathechal injection into the csf	-	-	-	-	1件:  2  💬
181	Multiple (4 autologous subcutaneous t cell vaccinations with t cell lines reactive to nine myelin peptides)	-	-	-	-	1件: 13 💬
182	Nebcin (tobramycin)	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
183	Nebcinal tobi	-	-	-	-	1件: 299 💬
184	Nebulization tobramycin	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
185	Nexavar (bay 43-9006) (sorafenib)	Sorafenib	2件: D06272, D08524 💬	8件: BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬	87件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway	1件: 34 💬
186	Onabotulinum toxin a	-	-	-	-	1件: 226 💬
187	Opc-41061 (tolvaptan)	Tolvaptan	1件: D01213 💬	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	1件: 67 💬
188	Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone	Mesalazine	7件: D00377, D00407, D00751, D00979, D05000, D05001, D05002 💬	1件: NR3C1 💬	1件: Neuroactive ligand-receptor interaction	1件: 97 💬
189	Oral glucose tolerance test (75g 2-hour)	Dextrose, unspecified form	-	-	-	1件: 299 💬
190	Osu 6162 similar to (-)-osu 6162	-	-	-	-	1件:  6  💬
191	Osu6162 similar to (-)-osu 6162	-	-	-	-	2件:  6 ,  8  💬
192	Other: acute response to high-impact exercise	-	-	-	-	1件: 96 💬
193	Other: bmi greater than or equal to 30kg/m2 scheduled for psg. undergo blood draw (arterial blood gas and metabolic panel) and data collection from psg study.	-	-	-	-	1件: 230 💬
194	Other: bmi greater than or equal to 30kg/m2 scheduled for psg. undergo blood draw (venous blood gas and metabolic panel) and data collection from psg study.	-	-	-	-	1件: 230 💬
195	Other: diagnostics for glucose tolerance with 3 different methods.	Dextrose, unspecified form	-	-	-	1件: 299 💬
196	Other: dose reduction to 2mg/l	-	-	-	-	1件: 46 💬
197	Other: dose reduction to 5mg/l	-	-	-	-	1件: 46 💬
198	Other: eating assessment tool 10	-	-	-	-	1件:  2  💬
199	Other: eating assessment tool-10	-	-	-	-	1件:  2  💬
200	Other: glucose solution at a dose of 1.75 g/kg (up to a maximum of 75 g) for the ogtt and glucose solution at a dose of 0.5 g/kg (up to a maximum of 35 g) was injected in 2.5-3 min for the igtt	Dextrose, unspecified form	-	-	-	1件: 299 💬
201	Other: high resolution peripheral quantitative computed tomography (hrpqct)	-	-	-	-	1件: 172 💬
202	Other: mixed meal tolerance test	-	-	-	-	1件: 299 💬
203	Other: modified mixed meal tolerance test	-	-	-	-	1件: 65 💬
204	Other: modified oral glucose tolerance test	Dextrose, unspecified form	-	-	-	1件: 65 💬
205	Other: oral glucose tolerance test	Dextrose, unspecified form	-	-	-	3件: 160, 195, 299 💬
206	Other: oral glucose tolerance test (ogtt) assessment arm	Dextrose, unspecified form	-	-	-	1件: 299 💬
207	Other: recommendation with regard to nutrition	-	-	-	-	1件:  6  💬
208	Other: refered to general practice	-	-	-	-	1件: 46 💬
209	Other: screening to prevent falls	-	-	-	-	1件:  6  💬
210	Other: standard treatment according to the clinical protocols	-	-	-	-	1件: 49 💬
211	Other: standardized scales: mds-updrs (part ii to iv) and rdrs	-	-	-	-	1件:  6  💬
212	Other: the patients' parents have to complete the vineland ii adaptive behavior scales scoring, the sleep disturbance scale for children (sdsc) and horne & ostberg circadian typology questionnaire	-	-	-	-	1件: 149 💬
213	Other: tobacco questionnaire	Tobacco leaf	-	-	-	1件: 299 💬
214	Other: tobramycin time of administration	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
215	Patients will be randomized to receive ehp-101	-	-	-	-	1件: 51 💬
216	Pertussis toxoid adsorbed on aluminium hydroxide	Aluminium	1件: D02416 💬	-	-	1件: 46 💬
217	Pla + mtx switched to aba+ mtx, db	-	-	-	-	1件: 46 💬
218	Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) conjugated to crm197 carrier protein and adsorbed on aluminium phosphate	Aluminium	-	-	-	1件: 46 💬
219	Positron emission tomography using [11 carbon]-3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile ([11c]-dasb) and [18 fluorine]-altanserin ([18f]-altanserin)	Activated charcoal	1件: D03251 💬	-	-	1件:  6  💬
220	Positron emission tomography using [18 fluorine]-altanserin ([18f]-altanserin)	-	-	-	-	1件:  6  💬
221	Previously referred to as medi2070 and amg 139	-	-	-	-	2件: 96, 97 💬
222	Previously referred to as medi2070 and amg 139, agn-151-598	-	-	-	-	1件: 96 💬
223	Procedure: computed tomography	-	-	-	-	5件: 34, 40, 46, 49, 96 💬
224	Procedure: general anesthesia with tourniquet	-	-	-	-	1件: 46 💬
225	Procedure: general anesthesia without tourniquet	-	-	-	-	1件: 46 💬
226	Procedure: glucagon stimulation test and insulin tolerance test	Glucagon	2件: D00116, D02118 💬	1件: GCGR 💬	2件: Glucagon signaling pathway, Neuroactive ligand-receptor interaction	1件: 78 💬
227	Procedure: iv glucose tolerance test	Dextrose, unspecified form	-	-	-	1件: 299 💬
228	Procedure: oral glucose tolerance test	Dextrose, unspecified form	-	-	-	1件: 299 💬
229	Procedure: positron emission tomography	-	-	-	-	4件: 40, 46, 49, 96 💬
230	Procedure: single photon emission computed tomography	-	-	-	-	1件: 34 💬
231	Procedure: spinal anesthesia with tourniquet	-	-	-	-	1件: 46 💬
232	Procedure: spinal anesthesia without tourniquet	-	-	-	-	1件: 46 💬
233	Procedure: surgery to implant human cns stem cells (hucns-sc)	-	-	-	-	1件: 19 💬
234	Procedure: tof repair with trans-annular patch vs preservation of pv	-	-	-	-	1件: 215 💬
235	Procedure: total body irradiation	-	-	-	-	6件: 19, 20, 51, 60, 65, 285 💬
236	Procedure: total lymphoid irradiation	-	-	-	-	3件: 65, 284, 326 💬
237	Procedure: total thyroidectomy	-	-	-	-	1件: 235 💬
238	Procedure: total-body irradiation	-	-	-	-	1件: 51 💬
239	Procedure: treatment according to current standards without knowledge of serum infliximab and anti-infliximab ab status	Infliximab	1件: D02598 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 96 💬
240	Procedure: use of an electronic data capture system by patients and physicians to assess patient-physician interactions & therapeutic decisions & outcomes in ra subjects.	Bifenthrin	-	-	-	1件: 46 💬
241	Procedure: warm compress prior to injection of glatiramer acetate	Acetate	1件: D04318 💬	20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬	32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis	1件: 13 💬
242	Pxt3003 dose 2 (equivalent to twice dose 1)	-	-	-	-	1件: 10 💬
243	Qr-313 gel for topical (cutaneous) administration	-	-	-	-	1件: 36 💬
244	Radiation: computed tomography lung subtraction iodine mapping	Iodine	1件: D00108 💬	-	-	1件: 88 💬
245	Radiation: computerized tomography scan	-	-	-	-	1件: 98 💬
246	Radiation: cone beam computed tomography (cbct)	Tricyclazole	-	-	-	1件: 51 💬
247	Radiation: irradiation, total body	-	-	-	-	1件: 274 💬
248	Radiation: low-dose total body irradiation (tbi)	-	-	-	-	1件: 60 💬
249	Radiation: pet (positron emission tomography) study	-	-	-	-	1件: 17 💬
250	Radiation: single photon emission computed tomography scans	-	-	-	-	1件: 98 💬
251	Radiation: total body 200cgy	-	-	-	-	1件: 65 💬
252	Radiation: total body irradiation	-	-	-	-	7件: 36, 49, 51, 60, 65, 283, 284 💬
253	Radiation: total body irradiation (tbi)	-	-	-	-	3件: 60, 65, 285 💬
254	Radiation: total body irradiation 1200 cgy	-	-	-	-	1件: 60 💬
255	Radiation: total body irradiation 200 cgy	-	-	-	-	1件: 60 💬
256	Radiation: total body irradiation with marrow boosting	-	-	-	-	2件: 19, 234 💬
257	Radiation: total lymphoid irradiation	-	-	-	-	1件: 326 💬
258	Radiation: total lymphoid irradiation (tli)	-	-	-	-	2件: 60, 65 💬
259	Radiation: total-body irradiation	-	-	-	-	9件: 28, 51, 60, 62, 65, 96, 283, 284, 285 💬
260	Rapamycin cream, topical, 0.5%, 1.0% w/w	Sirolimus	1件: D00753 💬	1件: MTOR 💬	50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway	1件: 158 💬
261	Recombinant human monoclonal antibody to human il-1beta of the igg1/k class	-	-	-	-	3件: 106, 107, 108 💬
262	Recombinant human monoclonal antibody to il-17 of the igg1-k-class	-	-	-	-	1件: 271 💬
263	Recombinant human monoclonal antibody to inerleukin-1beta of the igg1-k-class	-	-	-	-	1件: 46 💬
264	Recombinant human monoclonal antibody to interleukin-1beta of the igg1-kappa-class	-	-	-	-	1件: 46 💬
265	Recombinant human serum albumin (hsa) fused to human growth hormone (hgh)	Albumin human	3件: D02691, D02792, D05424 💬	1件: GHR 💬	5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway	1件: 78 💬
266	Recombinant humanized monoclonal antibody omalizumab to ige	Omalizumab	1件: D05251 💬	1件: FCER1A 💬	4件: Asthma, Fc epsilon RI signaling pathway, Phospholipase D signaling pathway, Sphingolipid signaling pathway	1件: 299 💬
267	Reduced toxicity ablative regimen	-	-	-	-	3件: 62, 65, 284 💬
268	Response to anakinra associated with methotrexate	Anakinra	3件: D00142, D02115, D02934 💬	4件: DHFR, DHFR2, IL1R1, IL1R2 💬	20件: Amoebiasis, Antifolate resistance, Biosynthesis of cofactors, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Folate biosynthesis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, Metabolic pathways, NF-kappa B signaling pathway, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer	1件: 46 💬
269	Response to infliximab associated with methotrexate	Infliximab	3件: D00142, D02115, D02598 💬	3件: DHFR, DHFR2, TNF 💬	69件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
270	Rhumab to il-17a (igg1-k-class)	-	-	-	-	4件: 13, 46, 56, 96 💬
271	Rhumab to il-17a (igg1-k-class) rhumab to il-17a (igg1-k-class)	-	-	-	-	1件: 96 💬
272	Rhumab to il-17a igg1-k-class	-	-	-	-	1件: 13 💬
273	Rpc1063 (equivalent to ozanimod	Ozanimod	1件: D10968 💬	5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬	3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway	1件: 96 💬
274	Rpc1063 (equivalent to ozanimod hcl)	Ozanimod	1件: D10968 💬	5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬	3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway	1件: 96 💬
275	Sb2 (proposed biosimilar to infliximab)	Infliximab	1件: D02598 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
276	Sb4 (proposed biosimilar to etanercept)	Etanercept	1件: D00742 💬	2件: LTA, TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
277	Sb5 (proposed biosimilar to adalimumab)	Adalimumab	1件: D02597 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	1件: 46 💬
278	Sorafenib	Sorafenib	2件: D06272, D08524 💬	8件: BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬	87件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway	2件: 34, 86 💬
279	Sorafenib (as tosylate)	Sorafenib	2件: D06272, D08524 💬	8件: BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET 💬	87件: Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chemokine signaling pathway, Choline metabolism in cancer, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, VEGF signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway	1件: 34 💬
280	Subcutaneous tocilizumab	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 46 💬
281	Suplatast tosilate	-	-	-	-	1件: 226 💬
282	Switch to myfortic	-	-	-	-	1件: 49 💬
283	Takecab tablets + amoxicillin + clarithromycin (first-line eradication) takecab tablets + amoxicillin + metronidazole (second-line eradication)	Amoxicillin	7件: D00229, D00276, D00409, D02925, D05016, D05017, D07452 💬	-	-	1件: 63 💬
284	Tedizolid	Tedizolid	1件: D09685 💬	-	-	1件: 299 💬
285	Tedizolid iv	Tedizolid	1件: D09685 💬	-	-	1件: 299 💬
286	Tedizolid po	Tedizolid	1件: D09685 💬	-	-	1件: 299 💬
287	Temsirolimus	Temsirolimus	1件: D06068 💬	1件: MTOR 💬	50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway	4件: 13, 34, 89, 331 💬
288	Temsirolimus tablets	Temsirolimus	1件: D06068 💬	1件: MTOR 💬	50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway	1件: 13 💬
289	Teriparatide conjugated to a multiarm polyethylene glycol carrier molecule through a cleavable linker	Polyethylene glycol	2件: D03370, D06078 💬	1件: PTH1R 💬	3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action	1件: 235 💬
290	Tetanus diphtheria toxoid vaccine (td)	Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)	-	-	-	1件: 13 💬
291	Tetanus diphtheria toxoids vaccine	-	-	-	-	1件: 13 💬
292	Tetanus toxoid	Clostridium tetani toxoid antigen (formaldehyde inactivated)	-	-	-	2件: 13, 46 💬
293	Tetanus toxoid (tt) containing vaccine (td, tdap)	Clostridium tetani toxoid antigen (formaldehyde inactivated)	-	-	-	1件: 13 💬
294	Tetanus toxoid adsorbed	Clostridium tetani toxoid antigen (formaldehyde inactivated)	-	-	-	1件: 46 💬
295	Tetanus toxoid adsorbed booster vaccine	Clostridium tetani toxoid antigen (formaldehyde inactivated)	-	-	-	1件: 46 💬
296	Tetanus toxoid adsorbed vaccine	Clostridium tetani toxoid antigen (formaldehyde inactivated)	-	-	-	1件: 46 💬
297	Tetanus toxoid vaccine	Clostridium tetani toxoid antigen (formaldehyde inactivated)	-	-	-	1件: 13 💬
298	Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed)	Clostridium tetani toxoid antigen (formaldehyde inactivated)	1件: D06514 💬	-	-	1件: 46 💬
299	The investigational medicinal product (imp) will be labeled as pf-04236921 106 mg/vial, clonal sc lyophilized form, which is equivalent to pf-04236921 powder for injection, 106 mg/vial as described in the enclosed cta	-	-	-	-	1件: 96 💬
300	The investigational medicinal product (imp) will be labeled as pf-04236921 106 mg/vial, clonal sc lyophilized form, which is equivalent to pf-04236921 powder for injection, 106 mg/vial as described in the enclosed cta.	-	-	-	-	1件: 96 💬
301	Time delay treatment of botulinum toxin	-	-	-	-	1件: 149 💬
302	Tip (tobramycin inhalation powder)	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
303	Tis (tobramycin inhalation solution)	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
304	To	-	-	-	-	1件:  6  💬
305	To be confirmed	-	-	-	-	2件: 46, 97 💬
306	To be determined	-	-	-	-	1件: 96 💬
307	To be requested	-	-	-	-	2件: 96, 97 💬
308	Tobacco	Tobacco leaf	-	-	-	1件: 299 💬
309	Tobi	-	-	-	-	1件: 299 💬
310	Tobi (tobramycin)	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
311	Tobi 300 mg / 5 ml nebuliser solution	-	-	-	-	1件: 299 💬
312	Tobi 300 mg/5 ml lösung für einen	-	-	-	-	1件: 299 💬
313	Tobi 300 mg/5 ml lösung für einen vernebler	-	-	-	-	1件: 299 💬
314	Tobi 300 mg/5 ml nebuliser solution	-	-	-	-	1件: 299 💬
315	Tobi 300 mg/5 ml solución para inhalación por nebulizador	-	-	-	-	1件: 299 💬
316	Tobi 300 mg/5 ml, solution pour inhalation par nébuliseur	-	-	-	-	1件: 299 💬
317	Tobi 300mg/ 5ml solución para inhalación con nebulizador	-	-	-	-	1件: 299 💬
318	Tobi 300mg/5ml nebuliser solution	-	-	-	-	1件: 299 💬
319	Tobi 300mg/5ml nebuliser solution.	-	-	-	-	1件: 299 💬
320	Tobi 300mg/5ml solución para inhalación por nebulizador.	-	-	-	-	1件: 299 💬
321	Tobi inhalant product	-	-	-	-	1件: 299 💬
322	Tobi nebcinal	-	-	-	-	1件: 299 💬
323	Tobi podhaler	-	-	-	-	1件: 299 💬
324	Tobi podhaler - 28 mg polvere per inalazione capsula rigida uso inalatorio blister(alu/alu) 56 capsule + 1 inalatore	-	-	-	-	1件: 299 💬
325	Tobi podhaler 28 mg hartkapseln mit pulver zur inhalation	-	-	-	-	1件: 299 💬
326	Tobi podhaler 28 mg inhalációs por, kemény kapszula	-	-	-	-	1件: 299 💬
327	Tobi podhaler*448cps 28mg+10in	-	-	-	-	1件: 299 💬
328	Tobi*nebul 56f 1d 300mg/5ml	-	-	-	-	1件: 299 💬
329	Tobi®	-	-	-	-	1件: 299 💬
330	Tobi™ podhaler™ 112 mg inhaled twice daily	-	-	-	-	1件: 299 💬
331	Tobramcyin	-	-	-	-	1件: 299 💬
332	Tobramicina	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
333	Tobramicina polvere inalatoria	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
334	Tobramycin	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
335	Tobramycin (gernebcin®)	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
336	Tobramycin / bramitob	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
337	Tobramycin / tobi	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
338	Tobramycin 100 pari	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
339	Tobramycin dry powder	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
340	Tobramycin for inhalation	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
341	Tobramycin inhalation powder	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
342	Tobramycin inhalation powder (tip)	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
343	Tobramycin inhalation powder tip delivered by the t-326 inhaler	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
344	Tobramycin inhalation solution	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
345	Tobramycin inhalation solution (tis)	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
346	Tobramycin inhalation solution using a pari lc® plus nebulizer.	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
347	Tobramycin injection 40mg/1ml	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
348	Tobramycin nebulized nasally	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
349	Tobramycin powder	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
350	Tobramycin solution for inhalation	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
351	Tobramycin solution for inhalation (tobi)	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
352	Tobramycin solution for inhalation 300 mg	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
353	Tobramycin steri-neb 300 mg/5 ml, inhalation solution	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
354	Tobramycin sulfate	Sulfate ion	2件: D00063, D02542 💬	-	-	1件: 299 💬
355	Tobramycine	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
356	Tobramycinum	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
357	Tobrineb/bramitob	-	-	-	-	1件: 299 💬
358	Tocilizumab	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	18件:  2 , 13, 40, 41, 42, 43, 46, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 💬
359	Tocilizumab (actemra or roactemra)	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 46 💬
360	Tocilizumab (actemra)	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 46 💬
361	Tocilizumab (actemra®)	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 46 💬
362	Tocilizumab (mra-sc)	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 40 💬
363	Tocilizumab (tcz)	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	2件: 46, 56 💬
364	Tocilizumab + glucocorticoids (gcs)	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 41 💬
365	Tocilizumab + methotrexate(mtx)	Methotrexate	3件: D00142, D02115, D02596 💬	3件: DHFR, DHFR2, IL6R 💬	17件: Antifolate resistance, Biosynthesis of cofactors, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Folate biosynthesis, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Metabolic pathways, Non-alcoholic fatty liver disease, One carbon pool by folate, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 46 💬
366	Tocilizumab 162 mg	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 46 💬
367	Tocilizumab 162mg/0.9ml jeringa sc	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 46 💬
368	Tocilizumab 162mg/0.9ml sc pfs sc	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 46 💬
369	Tocilizumab 162mg/0.9ml syringe sc	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 46 💬
370	Tocilizumab [roactemra/actemra]	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	4件: 46, 51, 107, 331 💬
371	Tocilizumab [roactemra]	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 46 💬
372	Tocilizumab and iv steroids combination	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 41 💬
373	Tocilizumab infusion roacemtra (eu)	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 266 💬
374	Tocilizumab injection	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 13 💬
375	Tocilizumab iv	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 46 💬
376	Tocilizumab plus methotrexate	Methotrexate	3件: D00142, D02115, D02596 💬	3件: DHFR, DHFR2, IL6R 💬	17件: Antifolate resistance, Biosynthesis of cofactors, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Folate biosynthesis, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Metabolic pathways, Non-alcoholic fatty liver disease, One carbon pool by folate, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 46 💬
377	Tocilizumab prefilled syringe	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 46 💬
378	Tocilizumab roche	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	2件: 46, 107 💬
379	Tocilizumab sc	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	3件: 41, 46, 107 💬
380	Tocilizumab sc 162 mg/0.9 ml disposable auto-injector (ai)	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 46 💬
381	Tocilizumab sc 162 mg/0.9 ml pre-filled syringe with safety device (pfs)	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 46 💬
382	Tocilizumab sc 162 mg/0.9 ml prefilled syringe with safety device (pfs)	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 51 💬
383	Tocilizumab treatment	Tocilizumab	1件: D02596 💬	1件: IL6R 💬	12件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 41 💬
384	Tocilizumab+methotrexate(mtx)	Methotrexate	3件: D00142, D02115, D02596 💬	3件: DHFR, DHFR2, IL6R 💬	17件: Antifolate resistance, Biosynthesis of cofactors, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Folate biosynthesis, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Metabolic pathways, Non-alcoholic fatty liver disease, One carbon pool by folate, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor	1件: 46 💬
385	Tocilizumab, abatacept	Abatacept	2件: D02596, D03203 💬	3件: CD80, CD86, IL6R 💬	24件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor	1件: 46 💬
386	Tocilizumabum	-	-	-	-	1件: 46 💬
387	Tocoferol	Tocopherol	1件: D02332 💬	-	-	1件: 90 💬
388	Tocopherol	Tocopherol	1件: D02332 💬	-	-	5件: 13, 49, 206, 257, 298 💬
389	Tocopherol (vit e)	Tocopherol	1件: D02332 💬	-	-	1件: 257 💬
390	Tocopherol acetate	Acetate	1件: D02332 💬	-	-	1件: 49 💬
391	Tocopheryl acetate	Acetate	-	-	-	1件: 206 💬
392	Tocotrienol	Tocotrienol	-	-	-	2件: 156, 299 💬
393	Tocotrienols	-	-	-	-	1件:  2  💬
394	Tocovid suprabio	-	-	-	-	1件:  6  💬
395	Toctino	-	-	-	-	1件: 49 💬
396	Toctino®	-	-	-	-	1件: 49 💬
397	Tofacitinb	-	-	-	-	1件: 46 💬
398	Tofacitinib	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬
399	Tofacitinib (cp-690,550)	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 96 💬
400	Tofacitinib (xeljanz)	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 46 💬
401	Tofacitinib (xeljanz®)	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 46 💬
402	Tofacitinib (xeljanz®) 11mg prolonged release tablet	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 46 💬
403	Tofacitinib 10 mg	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 271 💬
404	Tofacitinib 2 mg	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 271 💬
405	Tofacitinib 5 mg	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	3件: 11, 46, 271 💬
406	Tofacitinib 5 mg [xeljanz]	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	2件: 46, 50 💬
407	Tofacitinib 5 mg twice daily	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 84 💬
408	Tofacitinib 5mg [xeljanz] 1 year open-label extension	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 84 💬
409	Tofacitinib 5mg oral tablet [xeljanz] 16 week trial	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 84 💬
410	Tofacitinib 5mg po bid	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 46 💬
411	Tofacitinib citate (phase iii formulation)	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 46 💬
412	Tofacitinib citrate	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	5件: 46, 49, 97, 107, 271 💬
413	Tofacitinib citrate (clinical trial image)	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	2件: 46, 97 💬
414	Tofacitinib citrate (commercial image)	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 46 💬
415	Tofacitinib citrate (phase iii formulation)	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	2件: 46, 97 💬
416	Tofacitinib citrate (proposed commercial formulation - debossed)	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	2件: 46, 97 💬
417	Tofacitinib citrate (proposed commercial formulation debossed)	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 46 💬
418	Tofacitinib citrate (proposed commercial formulation – debossed)	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	2件: 46, 97 💬
419	Tofacitinib citrate (proposed commercial formulation- debossed)	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 46 💬
420	Tofacitinib citrate (proposed commercialformulation - debossed)	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 97 💬
421	Tofacitinib citrate cp-690550	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 46 💬
422	Tofacitinib citrate( phase iii formulation)	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 46 💬
423	Tofacitinib or baricitinib	Baricitinib	2件: D09970, D10308 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 46 💬
424	Tofacitinib tablet	Tofacitinib	1件: D09970 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 40 💬
425	Tofacitinib with methotrexate	Methotrexate	3件: D00142, D02115, D09970 💬	6件: DHFR, DHFR2, JAK1, JAK2, JAK3, TYK2 💬	40件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Antifolate resistance, Biosynthesis of cofactors, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Folate biosynthesis, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, Metabolic pathways, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, One carbon pool by folate, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 46 💬
426	Tofacitinib without methotrexate	Methotrexate	3件: D00142, D02115, D09970 💬	6件: DHFR, DHFR2, JAK1, JAK2, JAK3, TYK2 💬	40件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Antifolate resistance, Biosynthesis of cofactors, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Folate biosynthesis, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, Metabolic pathways, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, One carbon pool by folate, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 46 💬
427	Tofacitinib/baricitinib	Baricitinib	2件: D09970, D10308 💬	4件: JAK1, JAK2, JAK3, TYK2 💬	35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis	1件: 46 💬
428	Tofacitinibe citrate	-	-	-	-	1件: 107 💬
429	Tolcapon	Tolcapone	1件: D00786 💬	1件: COMT 💬	4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism	1件:  6  💬
430	Tolcapone	Tolcapone	1件: D00786 💬	1件: COMT 💬	4件: Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism	3件:  6 , 28, 127 💬
431	Toldc	-	-	-	-	1件: 46 💬
432	Tolerogenic dendritic cells	-	-	-	-	2件: 46, 96 💬
433	Tolerogenic dendritic cells (toldc)	-	-	-	-	1件: 13 💬
434	Tolerogenic dendritic cells loaded with myelin peptides	-	-	-	-	1件: 13 💬
435	Tolfenamic acid	Tolfenamic acid	1件: D01183 💬	2件: PTGS1, PTGS2 💬	23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway	1件:  5  💬
436	Tolicizumab	-	-	-	-	1件: 46 💬
437	Tolicizumab roche	-	-	-	-	1件: 46 💬
438	Tolperisone	Tolperisone	1件: D08617 💬	-	-	1件: 13 💬
439	Tolperisone hc1	Tolperisone	1件: D08617 💬	-	-	1件: 13 💬
440	Tolperisone hcl	Tolperisone	1件: D08617 💬	-	-	1件: 13 💬
441	Tolpersan	-	-	-	-	1件: 13 💬
442	Tolposan	-	-	-	-	1件: 13 💬
443	Tolubuterol hydrochloride	-	-	-	-	1件:  6  💬
444	Tolvaptan	Tolvaptan	1件: D01213 💬	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	3件: 67, 72, 225 💬
445	Tolvaptan (opc-41061)	Tolvaptan	1件: D01213 💬	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	1件: 67 💬
446	Tolvaptan 15	Tolvaptan	1件: D01213 💬	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	1件: 67 💬
447	Tolvaptan 15 mg tablet	Tolvaptan	1件: D01213 💬	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	1件: 67 💬
448	Tolvaptan 15 mg tablets	Tolvaptan	1件: D01213 💬	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	1件: 67 💬
449	Tolvaptan 15mg	Tolvaptan	1件: D01213 💬	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	1件: 67 💬
450	Tolvaptan 30	Tolvaptan	1件: D01213 💬	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	1件: 67 💬
451	Tolvaptan 30 mg tablet	Tolvaptan	1件: D01213 💬	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	1件: 67 💬
452	Tolvaptan 30 mg tablets	Tolvaptan	1件: D01213 💬	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	1件: 67 💬
453	Tolvaptan 30mg	Tolvaptan	1件: D01213 💬	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	1件: 67 💬
454	Tolvaptan 45/15	Tolvaptan	1件: D01213 💬	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	1件: 67 💬
455	Tolvaptan 60/30	Tolvaptan	1件: D01213 💬	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	1件: 67 💬
456	Tolvaptan 7.5 mg tablet	Tolvaptan	1件: D01213 💬	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	1件: 67 💬
457	Tolvaptan in euvolemic hyponatremia	Tolvaptan	1件: D01213 💬	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	1件: 72 💬
458	Tolvaptan ir	Tolvaptan	1件: D01213 💬	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	1件: 67 💬
459	Tolvaptan mr	Tolvaptan	1件: D01213 💬	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	1件: 67 💬
460	Tolvaptan oral tablet	Tolvaptan	1件: D01213 💬	1件: AVPR2 💬	3件: Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption	1件: 72 💬
461	Tominersen	-	-	-	-	1件:  8  💬
462	Top-down	-	-	-	-	1件: 96 💬
463	Top1288	-	-	-	-	1件: 97 💬
464	Top1288 rectal solution	-	-	-	-	1件: 97 💬
465	Topamax	-	-	-	-	1件: 140 💬
466	Topical 0.1% sirolimus	Sirolimus	1件: D00753 💬	1件: MTOR 💬	50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway	1件: 278 💬
467	Topical amphimatrix	-	-	-	-	1件: 51 💬
468	Topical amphimatrix with nitroglycerin (mqx-503)	Nitroglycerin	1件: D00515 💬	-	-	1件: 51 💬
469	Topical beremagene geperpavec	-	-	-	-	1件: 36 💬
470	Topical bpm31510 3.0% cream	-	-	-	-	1件: 36 💬
471	Topical calcipotriene 0.005% ointment	Calcipotriol	1件: D01125 💬	1件: VDR 💬	4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis	1件: 51 💬
472	Topical compound tripterygium	Tripterygium wilfordii whole	-	-	-	1件: 46 💬
473	Topical infliximab	Infliximab	1件: D02598 💬	1件: TNF 💬	65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway	3件: 38, 39, 162 💬
474	Topical opiod	-	-	-	-	1件: 36 💬
475	Topical organogel with nitroglycerin	Nitroglycerin	1件: D00515 💬	-	-	1件: 51 💬
476	Topical pentoxifylline gel (vehicle +ptx)	Pentoxifylline	1件: D00501 💬	-	-	1件: 56 💬
477	Topical preparation h arm	-	-	-	-	1件: 13 💬
478	Topical rapamycin	-	-	-	-	1件: 157 💬
479	Topical timolol maleate	Timolol	3件: D00378, D00603, D08600 💬	2件: ADRB1, ADRB2 💬	10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway	1件: 227 💬
480	Topical tripterygium gel	Tripterygium wilfordii whole	-	-	-	1件: 46 💬
481	Topical vehicle	-	-	-	-	1件: 278 💬
482	Topimarate	-	-	-	-	1件: 144 💬
483	Topimarato	-	-	-	-	1件: 144 💬
484	Topiramate	Topiramate	1件: D00537 💬	36件: CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	52件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	5件:  6 , 140, 144, 156, 193 💬
485	Topiramate (drug)	Topiramate	1件: D00537 💬	36件: CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬	52件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	1件:  6  💬
486	Topotecan	Topotecan	2件: D02168, D08618 💬	-	-	1件: 25 💬
487	Torvast	-	-	-	-	1件: 13 💬
488	Torvast*10cpr 10mg	-	-	-	-	1件: 13 💬
489	Total body irradiation (tbi) (plan 1)	-	-	-	-	2件: 60, 285 💬
490	Total dietary replacement	-	-	-	-	1件: 265 💬
491	Total glucosides paeony capsules	-	-	-	-	1件: 271 💬
492	Tovaxin	-	-	-	-	1件: 13 💬
493	Tovaxin autologous t cell vaccine	-	-	-	-	1件: 13 💬
494	Toxicity, pharmacokinetics	-	-	-	-	1件: 34 💬
495	Toz	-	-	-	-	1件:  6  💬
496	Tozadenant	Tozadenant	1件: D10174 💬	1件: ADORA2A 💬	7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway	1件:  6  💬
497	Tozadenant (syn115) 120 mg bid	Tozadenant	1件: D10174 💬	1件: ADORA2A 💬	7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway	1件:  6  💬
498	Tozadenant (syn115) 180 mg bid	Tozadenant	1件: D10174 💬	1件: ADORA2A 💬	7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway	1件:  6  💬
499	Tozadenant (syn115) 240 mg bid	Tozadenant	1件: D10174 💬	1件: ADORA2A 💬	7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway	1件:  6  💬
500	Tozadenant (syn115) 60 mg bid	Tozadenant	1件: D10174 💬	1件: ADORA2A 💬	7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway	1件:  6  💬
501	Treat to target	-	-	-	-	1件: 46 💬
502	Treatment with topical superpotent corticosteroid therapy	-	-	-	-	1件: 162 💬
503	Untreated to atorvastatin treatment	Atorvastatin	3件: D00258, D00887, D07474 💬	1件: HMGCR 💬	4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis	1件: 13 💬
504	Urine samples taken to measure methotrexate and its major metabolite 7-oh-methotrexate level	Methotrexate	2件: D00142, D02115 💬	2件: DHFR, DHFR2 💬	5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate	1件: 46 💬
505	Ursodeoxycholic acid combined with total glucosides of paeony	Ursodeoxycholic acid	1件: D00734 💬	1件: NR1H4 💬	1件: Bile secretion	1件: 93 💬
506	Vantobra (tobramycin)	Tobramycin	2件: D00063, D02542 💬	-	-	1件: 299 💬
507	Vehicle of adx-102 topical dermal cream	-	-	-	-	1件: 160 💬
508	Wound topically irrigated with 500mg txa	-	-	-	-	1件: 70 💬

先頭へ